埃克森美孚(XOM.US)據報尋求出售蘇格蘭及比利時化工廠 作價或達10億歐元
《金融時報》引述消息報道,埃克森美孚(XOM.US)尋求出售在英國和比利時的歐洲化工廠,最近數周與顧問進行初步討論。交易金額或高達10億美元。埃克森美孚在蘇格蘭Fife鎮擁有一座乙烯工廠,在比利時亦有多個生產基地。
報道指,公司曾討論直接關閉有關工廠,又指公司最終可能選擇繼續保留有關資產。
埃克森美孚與加拿大能源集團North Atlantic的法國子公司今年5月展開獨家談判,擬出售其持有多數股權的法國子公司Esso。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.